Globe Life INC Form 4 insider transactions

Robert Brian Mitchell, EVP, General Counsel and CRO of Globe Life Inc., sold 23,000 shares of common stock on August 7, 2026.

James Matthew Darden, Co-Chairman & CEO and a Director of Globe Life Inc., sold 50,000 shares of common stock on July 31, 2026.

Thomas Peter Kalmbach, EVP & CFO of Globe Life Inc., sold 21,000 shares of common stock on July 30, 2026.

Michael Clay Majors, EVP - Chief Strategy Officer of Globe Life Inc., sold 37,000 shares of common stock on July 29, 2026.

Thomas Peter Kalmbach, EVP & CFO of Globe Life Inc., sold 25,650 shares of common stock on July 28, 2026.

Globe Life Inc. reports insider trading activity where EVP Dolores L. Skarjune sold 1,850 shares of common stock.

Globe Life Inc. Director Cheryl Alston reported transactions involving the acquisition and disposition of company common stock on June 25, 2026.

Globe Life Inc. EVP and Chief Administrative Officer Dolores L. Skarjune exercised stock options and sold shares on June 12, 2026.

Robert Brian Mitchell, EVP and General Counsel of Globe Life Inc., reported a gift of 1,250 shares of common stock.

Frank M. Svoboda, Co-Chairman & CEO of Globe Life Inc., reported significant stock transactions, including acquisitions and dispositions of common stock and employee stock options.

Globe Life EVP and General Counsel Robert Brian Mitchell reported a series of stock sales and a gift transaction.

Globe Life Inc. EVP & CFO Thomas Peter Kalmbach acquired 10,000 shares of common stock and sold 7,936 shares, as detailed in a recent SEC Form 4 filing.

Frank M. Svoboda, Co-Chairman & CEO of Globe Life Inc., reported significant stock transactions on May 22, 2026, including the acquisition of 20,000 shares and the disposition of 18,410 and 1,590 shares.

Globe Life Inc. EVP & CFO Thomas Peter Kalmbach reported transactions involving the acquisition of 15,000 shares and the disposition of 11,903 shares of common stock.

Globe Life Inc. EVP & CFO Thomas P. Kalmbach exercised 35,000 stock options and sold a portion of the resulting shares.

Michael Shane Henrie, SVP & Chief Accounting Officer of Globe Life Inc., reported transactions involving the sale of company common stock.

Frank M. Svoboda, Co-Chairman & CEO of Globe Life Inc., reported significant transactions involving the acquisition and disposition of company common stock.

Globe Life Inc. reports insider transactions involving Co-Chairman & CEO James Matthew Darden, including stock acquisitions and sales.

Globe Life Inc. reports insider transactions by Co-Chairman & CEO Frank M. Svoboda, involving the acquisition of 10,000 shares and the sale of 9,900 shares.

Globe Life Inc. reports insider transactions, with Co-Chairman & CEO James Matthew Darden selling a portion of his common stock holdings.

Globe Life Inc. reports transactions by Co-Chairman & CEO James Matthew Darden involving the acquisition and disposition of common stock and employee stock options.

Globe Life Inc. executive Michael Majors reported transactions involving the sale of company stock and the exercise of employee stock options.

Michael Shane Henrie, SVP & Chief Accounting Officer of Globe Life Inc., reported transactions involving the acquisition and disposition of common stock.

Rebecca E. Zorn, EVP & Chief Talent Officer at Globe Life Inc., exercised stock options and subsequently sold all acquired common stock holdings.

Sandra L. Phillips, a Director at Globe Life Inc., reported the acquisition of 1,174 shares of common stock at a price of $0.

Globe Life Inc. Director Derek T. Kan acquired 6,433 stock options with an exercise price of $137.62, exercisable starting September 18, 2026.

Globe Life Inc. Co-Chairman and CEO Frank M. Svoboda reported the transfer of 5,000 common shares between family trusts under a Rule 10b5-1 plan.

Globe Life Inc. Co-Chairman and CEO James Matthew Darden reported recent stock transactions, including option exercises, share sales, and a transfer to a trust.

Globe Life Inc.'s EVP, General Counsel, and CRO, Robert Brian Mitchell, reported a gift transfer of 6,497 common shares to a family trust under a Rule 10b5-1 plan.

Globe Life Inc.'s EVP & Chief Investment Officer, Robert Edward Hensley, reported a planned sale of 2,569 shares of common stock at $145.0449 per share, effective March 2, 2026.